Literature DB >> 34341051

Evidence of the Feasibility and Preliminary Efficacy of Oncology Financial Navigation: A Scoping Review.

Meredith J Doherty1, Bridgette Thom2, Francesca Gany2,3.   

Abstract

One in three cancer patients reports financial hardship. Cancer-related financial hardship is associated with diminished quality of life, treatment nonadherence, and early mortality. Over 80% of NCI-designated cancer centers provide some form of oncology financial navigation (OFN). Although interest in OFN has grown, there is little scientific evidence to guide care delivery. We conducted a scoping review to assess the evidence of OFN's feasibility and preliminary efficacy and determine its core components/functions. Papers were included that (i) evaluated a clinical intervention to reduce financial hardship in patients with cancer or caregivers by facilitating access to resources, (ii) were conducted in the United States, and (iii) were published since 2000. Of 681 titles, 66 met criteria for full-text review, and six met full inclusion/exclusion criteria. The FN literature consists of descriptive studies and pilot trials focused on feasibility, acceptability, and preliminary efficacy. The studies showed that OFN implementation and evaluation are feasible; however, efficacy was difficult to evaluate because the studies were limited by small sample sizes (attributed to low patient participation). Most studies were conducted in urban, academic medical centers-which are less likely to be used by the poor and patients of color, who have the highest risk of financial hardship. The studies did not attempt to address the issue of underlying poverty at the individual and community level and whether OFN could be effectively adapted for these care environments. Future OFN programs must be tested with underserved and racially diverse patient populations, and evaluation efforts should aim to understand patient-reported barriers to participation. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2021        PMID: 34341051      PMCID: PMC9022465          DOI: 10.1158/1055-9965.EPI-20-1853

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.090


  31 in total

1.  Complex interventions: how "out of control" can a randomised controlled trial be?

Authors:  Penelope Hawe; Alan Shiell; Therese Riley
Journal:  BMJ       Date:  2004-06-26

Review 2.  Navigating financial assistance options for patients receiving specialty medications.

Authors:  Philip Schwieterman
Journal:  Am J Health Syst Pharm       Date:  2015-12-15       Impact factor: 2.637

3.  Piloting a Financial Counseling Intervention for Patients With Cancer Receiving Chemotherapy.

Authors:  Sheetal M Kircher; Jessica Yarber; Josh Rutsohn; Yanina Guevara; Madison Lyleroehr; Hannah Alphs Jackson; Jessica Walradt; Bijal Desai; Mary Mulcahy; Aparna Kalyan; Al B Benson; Mark Agulnik; Nisha Mohindra; Jonas DeSouza; Sofia F Garcia
Journal:  J Oncol Pract       Date:  2019-01-09       Impact factor: 3.840

4.  Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care?

Authors:  S Yousuf Zafar; Jeffrey M Peppercorn
Journal:  J Clin Oncol       Date:  2017-05-01       Impact factor: 44.544

5.  Transforming Practices Through the Oncology Care Model: Financial Toxicity and Counseling.

Authors:  Daniel E Sherman
Journal:  J Oncol Pract       Date:  2017-06-07       Impact factor: 3.840

6.  Use of Charity Financial Assistance for Novel Oral Anticancer Agents.

Authors:  Adam J Olszewski; Andrew R Zullo; Christopher R Nering; Justin P Huynh
Journal:  J Oncol Pract       Date:  2018-02-13       Impact factor: 3.840

7.  Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science.

Authors:  Laura J Damschroder; David C Aron; Rosalind E Keith; Susan R Kirsh; Jeffery A Alexander; Julie C Lowery
Journal:  Implement Sci       Date:  2009-08-07       Impact factor: 7.327

8.  A Pilot Study of a Comprehensive Financial Navigation Program in Patients With Cancer and Caregivers.

Authors:  Kate Watabayashi; Jordan Steelquist; Karen A Overstreet; Anthony Leahy; Erin Bradshaw; Kathleen D Gallagher; Alan J Balch; Rebecca Lobb; Laura Lavell; Hannah Linden; Scott D Ramsey; Veena Shankaran
Journal:  J Natl Compr Canc Netw       Date:  2020-10-01       Impact factor: 11.908

9.  Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer.

Authors:  Scott D Ramsey; Aasthaa Bansal; Catherine R Fedorenko; David K Blough; Karen A Overstreet; Veena Shankaran; Polly Newcomb
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

10.  Developing and evaluating complex interventions: the new Medical Research Council guidance.

Authors:  Peter Craig; Paul Dieppe; Sally Macintyre; Susan Michie; Irwin Nazareth; Mark Petticrew
Journal:  BMJ       Date:  2008-09-29
View more
  3 in total

1.  Financial Toxicity Interventions in Hematologic Malignancies Are Timely and Necessary.

Authors:  Christopher T Su
Journal:  JCO Oncol Pract       Date:  2022-07-08

2.  Financial burden for caregivers of adolescents and young adults with cancer.

Authors:  Chandylen L Nightingale; Mollie R Canzona; Suzanne C Danhauer; Bryce B Reeve; Dianna S Howard; Reginald D Tucker-Seeley; Shannon L S Golden; Denisha Little-Greene; Michael E Roth; David E Victorson; John M Salsman
Journal:  Psychooncology       Date:  2022-04-20       Impact factor: 3.955

3.  Lessening the Impact of Financial Toxicity (LIFT): a protocol for a multi-site, single-arm trial examining the effect of financial navigation on financial toxicity in adult patients with cancer in rural and non-rural settings.

Authors:  Stephanie B Wheeler; Caitlin B Biddell; Michelle L Manning; Mindy S Gellin; Neda R Padilla; Lisa P Spees; Cynthia D Rogers; Julia Rodriguez-O'Donnell; Cleo Samuel-Ryals; Sarah A Birken; Katherine E Reeder-Hayes; Victoria M Petermann; Allison M Deal; Donald L Rosenstein
Journal:  Trials       Date:  2022-10-03       Impact factor: 2.728

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.